Stratasys (NASDAQ:SSYS) Reports Slightly Better Than Expected First Quarter 2015 Earnings

Share this Article

s1With a deluge of negative news surrounding the 3D printing space, all eyes are on Eden Prairie, Minnesota-based Stratasys (NASDAQ:SSYS) this morning as they report their first quarter, 2015 earnings. Coming off a market shocker just under two weeks ago, where Stratasys issued preliminary results for the quarter, warning investors that the company will likely miss analysts’ expectations, lowering their full year guidance, and showing an 18% revenue decline for their subsidiary, MakerBot, investors now want to know just how bad this quarter has been.

Last week 3D Systems reported their earnings, which came in at about what analysts had been expecting. With that said the stock continued to fall, hitting new 52-week lows along with Stratasys. So what did this morning’s report offer the market? Pretty much what was expected.

s3

Stratasys reported earnings per share for the first quarter of $0.04, which was slightly better than the $0.03 per share average that analysts had been expecting. The company also slightly beat expectations on revenue, reporting $172.70 million for the quarter. Analysts had been expecting $172.60 million. Gross profit for the quarter ($46 million) fell well shy of last year’s first quarter in which the company reported a profit of $77.7 million.s4

“We continue to see significant long-term opportunity in the 3D printing and additive manufacturing market,” David Reis, chief executive officer of Stratasys stated. “We believe we are offering a transformative alternative to conventional manufacturing, design and engineering processes, and maintain an attractive pipeline of future opportunities. Although we have modified our near-term operating and capital investment plans to align with softness in market conditions, we will remain focused on the future, and continue to execute on a multi-year investment plan designed to drive accelerated adoption of 3D printing solutions and increased sales growth.”

The company reported total sales of 3D printers for the quarter, both from their MakerBot consumer brand as well as their industrial scale line of machines, of 7,536, and has sold a total of 129,197 machines on a pro forma combined basis worldwide as of March 31st of this year.

As for guidance for the full year, 2015, Stratasys is expecting earnings per share to fall somewhere between $1.20 and $1.70. This is slightly above the analyst consensus of $1.40 per share. Additionally, the company is expecting revenues of between $800 and $860 million for the year, once again s2trumping analysts’ estimates of $826.17 million.

In early trading, the market seems to like what they’ve seen in this report. Shares of Stratasys are trading up $0.86 or 2.43% in the pre-market.

The next several quarters will be important to watch, as the company has made significant moves within their consumer targeted MakerBot division, cutting costs and further integrating the subsidiary into their main operations. Let’s hear your thoughts on this latest report in the Stratasys Q1 Earnings forum thread on 3DPB.com.

Share this Article


Recent News

3D Printing Webinar and Event Roundup: October 6, 2024

3D Printing News Briefs, October 5, 2024: JIMTOF, Sensors, Façades, & More



Categories

3D Design

3D Printed Art

3D Printed Food

3D Printed Guns


You May Also Like

3D Printing Market Reaches $3.45B in Q2 2024, Marking 8.4% Year-Over-Year Growth

The global 3D printing market continued its upward trajectory in the second quarter of 2024, totaling $3.45 billion—a year-over-year increase of 8.4%. Despite a slight sequential decline from $3.47 billion...

Unlocking the Future of Investment Casting: 3D Systems’ Patrick Dunne on QuickCast Air

On the floor of this year’s International Manufacturing Technology Show (IMTS), the theme for original equipment manufacturers (OEMs) in additive manufacturing (AM) seemed to be indirect production. What if, by...

3D Printing Unpeeled: Screen Printing Drugs, Repair Process for Marines & PCL Drug Release

Contract development and manufacturing organization (CDMO) Adare Pharma Solutions, is partnering with Laxxon Medical. The CDMO will use Screen-Printed Innovative Drug (SPID) to make oral dosage forms where they hope...

Featured

FDA Clears 3D Systems’ New Multi-Material Solution for 3D Printed Dentures

3D Systems (NYSE: DDD), the additive manufacturing (AM) industry pioneer based in South Carolina, has achieved Food and Drug Administration (FDA) clearance for its one-piece, multi-material denture printing solution. 3D...